Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7507928rdf:typepubmed:Citationlld:pubmed
pubmed-article:7507928lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:7507928lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:7507928lifeskim:mentionsumls-concept:C0682972lld:lifeskim
pubmed-article:7507928lifeskim:mentionsumls-concept:C0041485lld:lifeskim
pubmed-article:7507928lifeskim:mentionsumls-concept:C0443301lld:lifeskim
pubmed-article:7507928lifeskim:mentionsumls-concept:C1709915lld:lifeskim
pubmed-article:7507928lifeskim:mentionsumls-concept:C0205250lld:lifeskim
pubmed-article:7507928lifeskim:mentionsumls-concept:C1546857lld:lifeskim
pubmed-article:7507928lifeskim:mentionsumls-concept:C1556066lld:lifeskim
pubmed-article:7507928lifeskim:mentionsumls-concept:C1619636lld:lifeskim
pubmed-article:7507928lifeskim:mentionsumls-concept:C1514873lld:lifeskim
pubmed-article:7507928pubmed:issue4lld:pubmed
pubmed-article:7507928pubmed:dateCreated1994-3-4lld:pubmed
pubmed-article:7507928pubmed:abstractTextAn aromatic residue, tyrosine 326 in the prototypical human beta 2-adrenergic receptor, exists in a highly conserved sequence motif in virtually all members of the G protein-coupled receptor family. The potential role of this conserved aromatic amino acid residue in the cellular processes of sequestration (a rapid internalization of the surface receptor) and down-regulation (a slower loss of total cellular receptors) associated with agonist-mediated desensitization of the beta 2-adrenergic receptor was assessed by replacing tyrosine residue 326 with an alanine residue (beta 2AR-Y326A). This mutation completely abolishes agonist-mediated receptor sequestration without affecting the ability of the receptor to activate maximally adenylyl cyclase, to undergo rapid desensitization, and to down-regulate in response to agonist. The only other major change associated with the mutated receptor is a complete loss of the ability to resensitize following rapid desensitization. These results imply that this tyrosine residue, which is part of a highly conserved sequence motif in G protein-coupled receptors, may be responsible for their agonist-mediated sequestration and that sequestration and down-regulation of the receptor are dissociable phenomena. The lack of resensitization in the sequestration-defective beta 2-adrenergic receptor mutant strongly suggests that the sequestration pathway is an important mechanism by which cells re-establish the normal responsiveness of G protein-coupled receptors following the removal of agonist.lld:pubmed
pubmed-article:7507928pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507928pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507928pubmed:languageenglld:pubmed
pubmed-article:7507928pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507928pubmed:citationSubsetIMlld:pubmed
pubmed-article:7507928pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507928pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507928pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507928pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507928pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507928pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507928pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507928pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507928pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507928pubmed:statusMEDLINElld:pubmed
pubmed-article:7507928pubmed:monthJanlld:pubmed
pubmed-article:7507928pubmed:issn0021-9258lld:pubmed
pubmed-article:7507928pubmed:authorpubmed-author:LefkowitzR...lld:pubmed
pubmed-article:7507928pubmed:authorpubmed-author:CaronM GMGlld:pubmed
pubmed-article:7507928pubmed:authorpubmed-author:BarakL SLSlld:pubmed
pubmed-article:7507928pubmed:authorpubmed-author:KwatraM MMMlld:pubmed
pubmed-article:7507928pubmed:authorpubmed-author:TiberiMMlld:pubmed
pubmed-article:7507928pubmed:authorpubmed-author:FreedmanN JNJlld:pubmed
pubmed-article:7507928pubmed:issnTypePrintlld:pubmed
pubmed-article:7507928pubmed:day28lld:pubmed
pubmed-article:7507928pubmed:volume269lld:pubmed
pubmed-article:7507928pubmed:ownerNLMlld:pubmed
pubmed-article:7507928pubmed:authorsCompleteYlld:pubmed
pubmed-article:7507928pubmed:pagination2790-5lld:pubmed
pubmed-article:7507928pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:meshHeadingpubmed-meshheading:7507928-...lld:pubmed
pubmed-article:7507928pubmed:year1994lld:pubmed
pubmed-article:7507928pubmed:articleTitleA highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated beta 2-adrenergic receptor sequestration.lld:pubmed
pubmed-article:7507928pubmed:affiliationHoward Hughes Medical Institute Laboratories, Duke University Medical Center, Durham, North Carolina 27710.lld:pubmed
pubmed-article:7507928pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7507928pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:7507928pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:7507928pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507928lld:pubmed
More...